Finding Clarity in Your Cancer Diagnosis Journey
When you or your loved one faces concerns about soft tissue tumours, the uncertainty can feel overwhelming. We understand that waiting for answers about potential rhabdomyosarcoma creates immense stress and anxiety. Our FOXO1 Break Apart FISH test is designed to provide the definitive molecular confirmation you need to move forward with confidence in your treatment plan.
Understanding Your FOXO1 FISH Test
The FOXO1 Break Apart FISH (Fluorescence In Situ Hybridization) test is a specialised molecular diagnostic tool that detects specific genetic rearrangements associated with alveolar rhabdomyosarcoma. This advanced testing method examines your tumour tissue at the chromosomal level, looking for the characteristic genetic changes that confirm this rare cancer type. Unlike standard pathology, FISH testing provides molecular-level precision that guides targeted treatment decisions.
Who Should Consider This Test?
This test is particularly important if you’re experiencing:
- Unexplained lumps or masses in muscle tissue
- Persistent pain or swelling in arms, legs, or trunk
- Suspected soft tissue sarcoma on imaging scans
- Previous inconclusive biopsy results requiring molecular confirmation
- Family history of childhood cancers or genetic syndromes
Early and accurate diagnosis is crucial for determining the most effective treatment approach for alveolar rhabdomyosarcoma.
Why This Test Matters for Your Health
Getting the right diagnosis early can significantly impact your treatment outcomes. The FOXO1 FISH test provides:
- Definitive Diagnosis: Confirms alveolar rhabdomyosarcoma with molecular precision
- Treatment Guidance: Helps oncologists choose the most appropriate therapy
- Peace of Mind: Reduces diagnostic uncertainty and anxiety
- Prognostic Information: Provides insights about disease characteristics
- Clinical Trial Eligibility: May open access to targeted therapies
Understanding Your Test Results
We know waiting for results can be stressful. Our team provides clear, comprehensive reports that your healthcare provider will discuss with you. A positive result confirms alveolar rhabdomyosarcoma, while a negative result helps rule out this specific subtype. Either way, you’ll have valuable information to guide next steps in your care journey.
Turnaround Time: 7-8 days from sample receipt
Sample Required: Paraffin-embedded tumour tissue blocks
Transparent Pricing for Peace of Mind
| Test Description | Regular Price | Special Price |
|---|---|---|
| FOXO1 Break Apart FISH Alveolar Rhabdomyosarcoma Diagnostic | ZAR 3,000 |
Note: This test requires a doctor’s prescription and is not applicable for surgery preparation, pregnancy cases, or travel abroad documentation.
Why Trust Oracle Genomics?
We’re committed to providing South Africans with access to world-class cancer diagnostics:
- Nationwide Coverage: Serving patients in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Medical Expertise: Partnering with leading oncologists and pathologists
- Accuracy Focus: Utilising advanced FISH technology for precise results
- Patient-Centred Care: Empathetic support throughout your testing journey
- Fast Turnaround: Quick results to reduce waiting anxiety
Take the Next Step Toward Clarity
Don’t let diagnostic uncertainty delay your treatment journey. Early and accurate diagnosis is your first step toward effective cancer management.
Limited Time Offer: Save ZAR 1,000 on this essential diagnostic test. Contact us today to schedule your testing through your healthcare provider.
